22157.jpg
mRNA Therapeutics and mRNA Vaccines Market Report 2022: Huge Amounts of Preclinical and Trial Data Point to Promising Future for the Sector
November 29, 2022 08:38 ET | Research and Markets
Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and mRNA Vaccines Market by Route of Administration, Therapeutic Area, and Geography: Global Trends and Industry Analysis, 2022-2035"...
Logo.PNG
HilleVax to Participate in November Investor Conferences
November 10, 2022 18:30 ET | HilleVax, Inc.
BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
22157.jpg
United States Vaccine Market Analysis Report 2022: Influenza Vaccine Market Expected To Rebound From Pandemic Dip
October 27, 2022 04:48 ET | Research and Markets
Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The "2022 United States Vaccine Market Report" report has been added to ResearchAndMarkets.com's offering. The U.S. vaccine market is expected to reach...
Global Vaccine Adjuvants Market Report (2022 to 2027) - Rising Funding for Vaccines and Infectious Disease Research Activities Presents Opportunities
October 04, 2022 08:53 ET | Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market by Product (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease...
emerge.png
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
September 06, 2022 06:30 ET | Emergent BioSolutions
GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its Phase 1 study evaluating the safety and...
Global Influenza Vaccines Market Report 2022-2028: Increasing Government Support to Promote Influenza Vaccination and Rising Investments by Top Market Players
September 05, 2022 06:38 ET | Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, and Route of Administration"...
Pediatric Vaccine Global Market Report 2022: Demand for Novel Vaccines Providing Immunization Against Both Infectious & Non-Communicable Diseases Presents Opportunities
August 23, 2022 05:23 ET | Research and Markets
Dublin, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The "Pediatric Vaccine Global Market Report 2022: By Vaccine, By Technology, By Application" report has been added to ResearchAndMarkets.com's offering. The...
logo 600X600.png
Global Enzyme Linked Immunosorbent Assay (ELISA) Market to Surpass US$ 3,004.3 Million by 2030, Says Coherent Market Insights (CMI)
July 22, 2022 09:40 ET | CMI
Seattle, July 22, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global Enzyme Linked Immunosorbent Assay (ELISA) market is estimated to be valued at US$ 2,016.1 million in 2022...
22157.jpg
mRNA Platform Global Market Report 2022: Rising Incidence of Coronavirus Cases Drive the Market Demand
July 14, 2022 04:08 ET | Research and Markets
Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "mRNA Platform - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Beyond Covid-19, mRNA-based...
Influenza Vaccines Global Market Report 2022: Demand for Universal Flu Vaccines Fuels the Need to Develop Innovative Approaches for Vaccine Development
July 05, 2022 04:18 ET | Research and Markets
Dublin, July 05, 2022 (GLOBE NEWSWIRE) -- The "Influenza Vaccines: Global Markets" report has been added to ResearchAndMarkets.com's offering.The report explains critical trends in the influenza...